107 related articles for article (PubMed ID: 2963016)
1. Evidences for a dopamine-regulated peripheral source of circulating beta-endorphin.
Genazzani AR; Petraglia F; Facchinetti F; Golinelli S; Oltramari P; Santoro V; Volpe A
J Clin Endocrinol Metab; 1988 Feb; 66(2):279-82. PubMed ID: 2963016
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
3. Dopamine regulates canine plasma beta-endorphin-immunoreactivity levels.
Sharp B; Ross R; Levin E; Sowers J
Endocrinology; 1982 May; 110(5):1828-30. PubMed ID: 6280976
[TBL] [Abstract][Full Text] [Related]
4. Serotoninergic agonists increase plasma levels of beta-endorphin and beta-lipotropin in humans.
Petraglia F; Facchinetti F; Martignoni E; Nappi G; Volpe A; Genazzani AR
J Clin Endocrinol Metab; 1984 Dec; 59(6):1138-42. PubMed ID: 6092410
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
Nagahama S; Chen YF; Oparil S
J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675
[TBL] [Abstract][Full Text] [Related]
6. Hyperendorphinemia in obese children and adolescents.
Genazzani AR; Facchinetti F; Petraglia F; Pintor C; Corda R
J Clin Endocrinol Metab; 1986 Jan; 62(1):36-40. PubMed ID: 2933422
[TBL] [Abstract][Full Text] [Related]
7. Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe.
Lamberts SW; Uitterlinden P; Bons EG; Zuiderwijk JM; Verleun T; Oosterom R; Hackeng WH
Endocrinology; 1984 Jun; 114(6):2349-53. PubMed ID: 6327244
[TBL] [Abstract][Full Text] [Related]
8. Proopiocortin-related peptide plasma levels throughout prepuberty and puberty.
Genazzani AR; Facchinetti F; Pintor C; Puggioni R; Parrini D; Petraglia F; Bagnoli F; Corda R
J Clin Endocrinol Metab; 1983 Jul; 57(1):56-61. PubMed ID: 6304136
[TBL] [Abstract][Full Text] [Related]
9. Discrimination between beta-endorphin and beta-lipotrophin in human plasma using two-site immunoradiometric assays.
Gibson S; Crosby SR; White A
Clin Endocrinol (Oxf); 1993 Oct; 39(4):445-53. PubMed ID: 8287571
[TBL] [Abstract][Full Text] [Related]
10. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
[TBL] [Abstract][Full Text] [Related]
11. Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels.
Autelitano DJ; Clements JA; Nikolaidis I; Canny BJ; Funder JW
Endocrinology; 1987 Nov; 121(5):1689-96. PubMed ID: 2959468
[TBL] [Abstract][Full Text] [Related]
12. A role for dopamine in growth hormone regulation in the dog.
Casanueva F; Betti R; Cocchi D; Zanardi P; Motta T; Müller EE
Endocrinology; 1981 Apr; 108(4):1469-75. PubMed ID: 7472276
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone fails to suppress hyperendorphinaemia of obese children.
Facchinetti F; Livieri C; Petraglia F; Cortona L; Severi F; Genazzani AR
Acta Endocrinol (Copenh); 1987 Sep; 116(1):90-4. PubMed ID: 2958981
[TBL] [Abstract][Full Text] [Related]
14. Effect of electroimmobilisation on ovine plasma concentrations of beta-endorphin/beta-lipotrophin, cortisol and prolactin.
Jephcott EH; McMillen IC; Rushen J; Hargreaves A; Thorburn GD
Res Vet Sci; 1986 Nov; 41(3):371-7. PubMed ID: 2949354
[TBL] [Abstract][Full Text] [Related]
15. Peripheral opioid secretory pattern in anorexia nervosa.
Brambilla F; Ferrari E; Petraglia F; Facchinetti F; Catalano M; Genazzani AR
Psychiatry Res; 1991 Nov; 39(2):115-27. PubMed ID: 1665917
[TBL] [Abstract][Full Text] [Related]
16. Bromocriptine is unable to suppress TRH-stimulated beta-endorphin/beta-lipotropin and cortisol secretion in normal pregnant women after delivery.
Lamberts SW; Angement R; van der Heijden A; Wladimiroff JW; Hackeng WH; de Jong FH
Horm Res; 1987; 27(4):195-9. PubMed ID: 2963790
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic regulation of alpha-melanocyte-stimulating hormone and N-acetyl-beta-endorphin secretion in the fetal lamb.
Newman CB; Wardlaw SL; Stark RI; Daniel SS; Frantz AG
Endocrinology; 1987 Mar; 120(3):962-6. PubMed ID: 3803322
[TBL] [Abstract][Full Text] [Related]
18. Steroid replacement treatment increases beta-endorphin and beta-lipotropin plasma levels in postmenopausal women.
Genazzani AR; Petraglia F; Facchinetti F; Grasso A; Alessandrini G; Volpe A
Gynecol Obstet Invest; 1988; 26(2):153-9. PubMed ID: 2851506
[TBL] [Abstract][Full Text] [Related]
19. Serotonin and dopamine independently regulate pituitary beta-endorphin release in vivo.
Sapun-Malcolm D; Farah JM; Mueller GP
Neuroendocrinology; 1986; 42(3):191-6. PubMed ID: 3005900
[TBL] [Abstract][Full Text] [Related]
20. Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women.
Petraglia F; De Leo V; Sardelli S; Mazzullo G; Gioffrè WR; Genazzani AR; D'Antona N
Gynecol Obstet Invest; 1987; 23(2):103-9. PubMed ID: 3583091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
